LONG-TERM EFFECTS OF ASPIRIN ON CARDIAC ALLOGRAFT VASCULOPATHY PROGRESSION AND ADVERSE OUTCOMES AFTER HEART TRANSPLANTATION

被引：0
|
作者：
Asleh, Rabea [1 ]
Briasoulis, Alexandros [1 ]
Lerman, Amir [1 ]
Smith, Byron [1 ]
Lopez, Camden [1 ]
Pereira, Naveen [1 ]
Edwards, Brooks [1 ]
Stulak, John [1 ]
Kremers, Walter [1 ]
Clavell, Alfredo [1 ]
Daly, Richard [1 ]
Kushwaha, Sudhir [1 ]
机构：
[1] Mayo Clin, Rochester, MN USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2020年 / 75卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1459-66
引用
收藏
页码：1074 / 1074
页数：1
相关论文
共 50 条
  • [21] PET Assessment of Cardiac Allograft Vasculopathy After Heart Transplantation
    Asleh, Rabea
    Kushwaha, Sudhir S.
    JACC-HEART FAILURE, 2023, 11 (05) : 566 - 568
  • [22] Different Cardiac Allograft Vasculopathy Progression is Observed Among Three Vessels After Heart Transplantation
    Ichibori, Yasuhiro
    Kotani, Jun-Ichi
    Tsukamoto, Yasumasa
    Ohtani, Tomohito
    Yamaguchi, Osamu
    Tachibana, Koichi
    Toda, Koichi
    Fukushima, Norihide
    Sawa, Yoshiki
    Sakata, Yasushi
    CIRCULATION, 2014, 130
  • [23] Factors associated with the cardiac allograft vasculopathy after heart transplantation
    Szczurek, W.
    Gasior, M.
    Skrzypek, M.
    Romuk, E.
    Zembala, M.
    Jurkiewicz, B. Szygula
    EUROPEAN HEART JOURNAL, 2020, 41 : 2697 - 2697
  • [24] The pharmaceutical management of cardiac allograft vasculopathy after heart transplantation
    Spitaleri, Giosafat
    Farrero Torres, Marta
    Sabatino, Mario
    Potena, Luciano
    EXPERT OPINION ON PHARMACOTHERAPY, 2020, 21 (11) : 1367 - 1376
  • [25] Factors associated with cardiac allograft vasculopathy after heart transplantation
    Szczurek-Wasilewicz, Wioletta
    Hawranek, Michal
    Skrzypek, Michal
    Hrapkowicz, Tomasz
    Gasior, Mariusz
    Warmusz, Oliwia
    Szygula-Jurkiewicz, Bozena
    POSTEPY W KARDIOLOGII INTERWENCYJNEJ, 2022, 18 (03): : 237 - 245
  • [26] Medication Management of Cardiac Allograft Vasculopathy After Heart Transplantation
    Hollis, Ian B.
    Reed, Brent N.
    Moranville, Michael P.
    PHARMACOTHERAPY, 2015, 35 (05): : 489 - 501
  • [27] Long-Term Mortality After Cardiac Allograft Vasculopathy Implications of Percutaneous Intervention
    Agarwal, Shikhar
    Parashar, Akhil
    Kapadia, Samir R.
    Tuzcu, E. Murat
    Modi, Dhruv
    Starling, Randall C.
    Oliveira, Guilherme H.
    JACC-HEART FAILURE, 2014, 2 (03) : 281 - 288
  • [28] Impact of Myocardial Bridging on Long-Term Mortality After Heart Transplantation: Risk Stratification With Ivus-Determined Cardiac Allograft Vasculopathy
    Kameda, Ryo
    Okada, Kozo
    Tanaka, Shigemitsu
    Luikart, Helen
    Yock, Paul G.
    Yeung, Alan C.
    Schnittger, Ingela
    Fitzgerald, Peter J.
    Khush, Kiran K.
    Fearon, William F.
    Honda, Yasuhiro
    CIRCULATION, 2018, 138
  • [29] Early Aspirin Initiation Following Heart Transplantation Decreases the Risk of Allograft Vasculopathy During Long-Term Follow-Up
    Peled, Y.
    Lavee, J.
    Raichlin, E.
    Katz, M.
    Shemesh, Y.
    Kassif, Y.
    Asher, E.
    Elian, D.
    Har-Zahav, Y.
    Shlomo, N.
    Goldenberg, I.
    Freimark, D.
    Klempfner, R.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2017, 36 (04): : S142 - S142
  • [30] Preventing cardiac allograft vasculopathy: Long-term beneficial effects of mycophenolate mofetil
    Kaczmarek, Ingo
    Ertl, Bjoern
    Schmauss, Daniel
    Sadoni, Sebastian
    Knez, Andreas
    Daebritz, Sabine
    Meiser, Bruno
    Reichart, Bruno
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2006, 25 (05): : 550 - 556
12345